Cholesterol & Lipid
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Risk Stratification & CV Prevention: Should Calcium Score Guide Lipid Management? The Power of Zero
FEATURING
Khurram Nasir
- 1,243 views
- January 5, 2022
- 11
Houston Methodist DeBakey Heart and Vascular Center
Debate: CCTA and FFR-CT Should Be the First Choice in the Assessment of Suspected CAD: Pro
FEATURING
Jonathon Leipsic
- 643 views
- January 5, 2022
- 11
World Stroke Organization
Supracardiac Atherosclerosis and Embolic Stroke of Undetermined Source
FEATURING
George Ntaios
- 64 views
- January 11, 2022
The North American Thrombosis Forum (NATF)
Clot Chronicles: Peripheral Artery Disease — What Clinicians Should Know
FEATURING
Mary Mcdermott
- 304 views
- January 13, 2022
- 4
Cardiometabolic Health Congress (CMHC)
CMHC Highlights: Discussion on Lipids and Atherosclerosis Risk Assessments
- 815 views
- January 18, 2022
- 9
Houston Methodist DeBakey Heart and Vascular Center
Directions of Cardiology in the Next Decade: 2022-2032
FEATURING
Eugene Braunwald
- 8,413 views
- January 24, 2022
- 50
Houston Methodist DeBakey Heart and Vascular Center
CAC Score for Aspirin Allocation
FEATURING
Miguel Cainzos-Achirica
- 391 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What Changed?
FEATURING
Michael Miedema
- 3,398 views
- January 25, 2022
- 25
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
FEATURING
Martha Gulati
- 3,175 views
- January 25, 2022
- 13
Houston Methodist DeBakey Heart and Vascular Center
Plaque Burden Is the Main Driver of Risk for Atherosclerotic Events: Beyond Coronary Stenosis
FEATURING
Martin Mortensen
- 255 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy
FEATURING
Jose Ferreiro
- 164 views
- January 25, 2022
- 2
Houston Methodist DeBakey Heart and Vascular Center
Aspirin: Not a "Wonder Drug" Anymore?
FEATURING
Miguel Cainzos-Achirica
- 433 views
- January 25, 2022
- 2
13th Orange County Symposium for Cardiovascular Disease Prevention
Atherosclerosis Is an Inflammatory Disease
FEATURING
Peter Toth
- 2,485 views
- January 26, 2022
- 20
13th Orange County Symposium for Cardiovascular Disease Prevention
The Gut Microbiome: Friend or Foe?
FEATURING
Rob Greenfield
- 1,197 views
- January 26, 2022
- 13
13th Orange County Symposium for Cardiovascular Disease Prevention
Top 10 Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction
FEATURING
Geeta Sikand
- 2,991 views
- January 26, 2022
- 16
13th Orange County Symposium for Cardiovascular Disease Prevention
Should We Have Lower LDL-C Goals?
FEATURING
Nathan Wong
- 1,826 views
- January 26, 2022
- 13
13th Orange County Symposium for Cardiovascular Disease Prevention
Novel Lipid-Lowering Drug Development Beyond Statins
FEATURING
Michael Wilkinson
- 1,907 views
- January 26, 2022
- 11
13th Orange County Symposium for Cardiovascular Disease Prevention
Panel Discussion
- 22 views
- January 26, 2022
13th Orange County Symposium for Cardiovascular Disease Prevention
Update on Calcium Screening and CTA: Role in Prevention
FEATURING
Matthew Budoff
- 24,875 views
- January 26, 2022
- 143
Cleveland Clinic Endocrinology & Metabolism Institute
Update on the Management of Hypercholesterolemia
FEATURING
Barbara Carranza Leon
- 1,004 views
- January 27, 2022
- 6
Cedars Sinai
Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curious Case of Our Nation's #1 Killer
FEATURING
James Forrester
- 9,504 views
- February 4, 2022
- 66
Cedars Sinai
What Triggers Inflammation in Atherosclerosis? Focus on Inflammasome
FEATURING
Prediman Shah
- 36 views
- February 4, 2022
Cedars Sinai
Repurposing Colchicine for Atherosclerosis
FEATURING
Jean-Claude Tardif
- 402 views
- February 4, 2022
- 2